• 中国科学论文统计源期刊
  • 中国科技核心期刊
  • 美国化学文摘(CA)来源期刊
  • 日本科学技术振兴机构数据库(JST)

临床输血与检验 ›› 2026, Vol. 28 ›› Issue (5): 787-795.DOI: 10.3969/j.issn.1671-2587.2026.05.018

• 综述 • 上一篇    下一篇

免疫细胞脂质代谢失衡在炎症性疾病中的作用及治疗前景*

陈梦柯, 夏荣   

  1. 复旦大学附属华山医院输血科,上海 200040
  • 收稿日期:2026-09-02 修回日期:2026-09-22 出版日期:2026-10-20 发布日期:2026-11-11
  • 通讯作者: 夏荣,主要从事输血相关免疫调节方面研究,(E-mail)rongxia@fudan.edu.cn。
  • 作者简介:陈梦柯,主要从事免疫炎症相关机制方面研究,(E-mail)24111220011@m.fudan.edu.cn。
  • 基金资助:
    *本课题受国家自然科学基金面上项目(No.82370232)资助

Role of Dysregulated Lipid Metabolism in Immune Cell in Inflammatory Diseases and Its Therapeutic Prospects

CHEN Mengke, XIA Rong   

  1. Department of Transfusion Medicine, Huashan Hospital, Fudan University, Shanghai 200040
  • Received:2026-09-02 Revised:2026-09-22 Online:2026-10-20 Published:2026-11-11

摘要: 免疫细胞脂质代谢失衡是连接代谢稳态与免疫炎症发生发展的关键环节。脂质代谢包括脂肪酸代谢、胆固醇代谢,以及鞘脂和磷脂代谢等过程,这些代谢过程的改变可重构免疫细胞膜结构与信号平台,进而驱动炎症信号放大、活性氧累积、吞噬与迁移功能异常以及免疫细胞功能状态失衡,最终促进自身免疫性疾病及多类慢性炎症性疾病的发生发展。近年来的研究进一步提示,代谢通路与免疫稳态之间存在复杂的时空调控网络,且不同免疫细胞及其亚群存在显著的代谢异质性,使得关键代谢节点的选择与疗效预测仍面临挑战。与此同时,靶向脂质代谢关键通路的干预策略已展现出一定的治疗潜力,包括他汀类药物与PCSK9抑制剂、LXR、AMPK和PPARγ信号调控以及脂肪酸合成相关通路抑制等,可能通过改善代谢紊乱并重塑免疫微环境来缓解炎症反应。本文就免疫细胞脂质代谢失衡在炎症性疾病中的作用机制进行综述,并总结当前脂质代谢靶向干预策略的研究进展及其转化应用,同时讨论关键科学问题与未来研究方向,以期为炎症性疾病的精准干预与个体化治疗提供理论依据与新思路。

关键词: 免疫细胞, 脂质代谢, 免疫代谢, 炎症性疾病, 代谢失衡, 治疗策略

Abstract: Dysregulated immune cell lipid metabolism is a critical link between metabolic homeostasis and the development and progression of immune-mediated inflammation. Lipid metabolism comprises fatty acid, cholesterol, sphingolipid, and phospholipid metabolism. Dysregulation of these metabolic processes can remodel immune cell membrane architecture and signaling platforms, thereby amplifying inflammatory signaling, promoting reactive oxygen species (ROS) accumulation, impairing phagocytosis and migratory functions, and disrupting immune cell functional states. Collectively, these alterations contribute to the development and progression of autoimmune diseases and other chronic inflammatory disorders. Emerging evidence further indicates that metabolic pathways and immune homeostasis are interconnected through complex spatiotemporal regulatory networks, and that distinct immune cell types and subsets exhibit pronounced metabolic heterogeneity. These features complicate the identification of key metabolic targets and the prediction of therapeutic responses. Meanwhile, therapeutic strategies targeting key lipid metabolic pathways have shown therapeutic potential, including statins and PCSK9 inhibitors, modulation of the LXR, AMPK, and PPARγ signaling, and inhibition of fatty acid synthesis-related pathways. Such interventions may alleviate metabolic dysregulation, reshape the immune microenvironment, and therefore mitigate inflammatory responses. In this review, we summarize the mechanisms by which immune cell lipid metabolism dysregulation contributes to inflammatory diseases, review current advances and translational applications of lipid metabolism-targeted interventions, and discuss key scientific questions and future research directions. These insights may inform precision interventions and individualized treatment of inflammatory diseases.

Key words: Immune cell, Lipid metabolism, Immunometabolism, Inflammatory diseases, Metabolic imbalance, Therapeutic strategies

中图分类号: